Navigation Links
Stroke Rehabilitation Through Modified Video Games

ediate feedback on his or her performance. And in an exercise to promote finger flexing speed, a patient tries to make a fist quickly enough to "scare away" a butterfly flitting around on the screen.

The engineers noted that the gaming glove they use doesn't have the accuracy and resolution of gloves designed specifically for rehabilitation, nor can it measure exact joint movement or provide force feedback. But such systems may be attractive for clinics that can't afford more expensive equipment and could open the door for supplemental home training with remote monitoring by a clinician over an Internet connection.

Source-Eurekalert
RAS
'"/>




Page: 1 2

Related medicine news :

1. Amphetamines Help Recovery of Stroke Patients
2. Cough Syrup Ingredient Linked to Stroke
3. Estrogen Does Not Prevent Recurrent Strokes
4. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
5. Triglycerides Linked To Stroke Risk
6. Strokes increased during squatting
7. Drug Combinations May Boost Stroke Risk
8. Stroke and Dementia - a ghastly association
9. Stroke risk might be linked to antibody
10. Stroke Risk and Fish :A factual interconnection
11. Fewer teeth & Increased Ischemic Stroke risk
Post Your Comments:
Breaking Medicine Technology:Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Dynatronics Receives 180-Day NASDAQ Extension 2Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 1YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 2YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 3OH2 Medical Spa Achieves the First U S LEED 28R 29 Certification for a Medical Commercial Interior 51691 1OH2 Medical Spa Achieves the First U S LEED 28R 29 Certification for a Medical Commercial Interior 51691 2Fitness Might Limit Strokes Impact 51687 1Fitness Might Limit Strokes Impact 51687 2